Introducing the Innovation Seed Grant: Supporting Early-Stage Angelman Syndrome Research
FAST launches the Innovation Seed Grant, offering $10,000–$50,000 to help researchers gather early-stage data on bold, high-risk approaches to Angelman syndrome treatment.
FAST Spain Awards First Research Grant
FAST Spain awards its first research grant to study two novel biomarkers—the endocannabinoid system and transcriptomic profile—to better track Angelman syndrome progression and treatment.